Zobrazeno 1 - 10 of 103 pro vyhledávání: '"Vishwa Jeet, Amatya"'
1
Akademický článek
Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1
Autor: Ihiro Endo, Vishwa Jeet Amatya, Kei Kushitani, Takahiro Kambara, Tetsuya Nakagiri, Yutaro Fujii, Yukio Takeshima
Publikováno v: Frontiers in Oncology, Vol 11 (2022)
Malignant mesothelioma is a tumor with a poor prognosis, mainly caused by asbestos exposure and with no adequate treatment yet. To develop future therapeutic targets, we analyzed the microarray dataset GSE 29370 of malignant mesothelioma and reactive
Externí odkaz: https://doaj.org/article/3f23dbe99c934e4caaabc215b12f2d82
Zobrazit plný text záznamu
2
Akademický článek
Effect of bevacizumab against cystic components of brain tumors
Autor: Fumiyuki Yamasaki, Manish Kolakshyapati, Motoki Takano, Ushio Yonezawa, Ikuno Nishibuchi, Nobuki Imano, Akira Taguchi, Shumpei Onishi, Vishwa Jeet Amatya, Yukio Takeshima, Yasushi Nagata, Kaoru Kurisu, Kazuhiko Sugiyama
Publikováno v: Cancer Medicine, Vol 8, Iss 15, Pp 6519-6527 (2019)
Abstract Background Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented ye
Externí odkaz: https://doaj.org/article/f8b3ff3bff194f8bbf58741f559e31d3
Zobrazit plný text záznamu
3
miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV
Autor: Ihiro Endo, Vishwa Jeet Amatya, Kei Kushitani, Tetsuya Nakagiri, Kohei Aoe, Yukio Takeshima
Publikováno v: Pathobiology. :1-11
Introduction: Malignant mesothelioma is an aggressive cancer associated with asbestos exposure. Currently, the efficacy of therapeutics is limited in malignant mesothelioma, and developing more effective therapies is the need of the hour. Non-coding
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a4b694cbfd302ba08aaddf7741481e1
https://doi.org/10.1159/000528670
Zobrazit plný text záznamu
4
Akademický článek
Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor
Autor: Tomoaki Naka, Yutaka Hatanaka, Yukiko Tabata, Akira Takasawa, Hideo Akiyama, Yasuhiro Hida, Hiromi Okada, Kanako C. Hatanaka, Tomoko Mitsuhashi, Kei Kushitani, Vishwa Jeet Amatya, Yukio Takeshima, Kouki Inai, Kichizo Kaga, Yoshihiro Matsuno
Publikováno v: Diagnostics, Vol 12, Iss 2, p 316 (2022)
Although the routine use of immunohistochemistry has improved the accuracy of histopathologic diagnosis in clinical practice, new methods for discovering novel diagnostic markers are still needed. We sought new diagnostic markers for malignant pleura
Externí odkaz: https://doaj.org/article/3320f9c47ffa4aa19288f39257050aa8
Zobrazit plný text záznamu
9
Data from CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma
Autor: Chikao Morimoto, Takumi Kishimoto, Kouki Inai, Yukio Takeshima, Nam H. Dang, Taketo Yamada, Masanori Fujii, Akio Hiraki, Osamu Hosono, Kei Ohnuma, Nobukazu Fujimoto, Vishwa Jeet Amatya, Keisuke Aoe
Purpose: Malignant pleural mesothelioma (MPM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells, without established indicators to predict responsiveness to chemotherapy.Experimental Design: Our study involvin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305a868318f2fa5f7f47bc374f47c28e
https://doi.org/10.1158/1078-0432.c.6520115
Zobrazit plný text záznamu
10
Akademický článek
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
Autor: Rui Suzuki, Vishwa Jeet Amatya, Kei Kushitani, Yuichiro Kai, Takahiro Kambara, Yukio Takeshima
Publikováno v: Frontiers in Oncology, Vol 8 (2018)
Dysregulation of miR-182 and miR-183 has been implicated in the progression of several human cancers. Our previous study showed that miR-182 and miR-183 are upregulated in malignant mesothelioma. However, their biological functions remain unclear. We
Externí odkaz: https://doaj.org/article/c85c5236e10649cd8ed56c39c4783b8c
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje